Francis E. O'Donnell, Jr.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-13–present
-
Current
2022-12-13–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inhibitor Therapeutics, Inc. (INTI) | Executive Chairman and Chief Executive Officer | $598,000 | $1,118,630 |
| 2024 | Inhibitor Therapeutics, Inc. (INTI) | Executive Chairman and Chief Executive Officer | $598,000 | $1,137,886 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.